Ignite Creation Date:
2025-12-25 @ 1:14 AM
Ignite Modification Date:
2025-12-25 @ 11:24 PM
Study NCT ID:
NCT00783393
Status:
COMPLETED
Last Update Posted:
2017-05-15
First Post:
2008-10-30
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
SCH 52365 Phase II Clinical Study: A Study on the Efficacy and Safety of Monotherapy With SCH 52365 in Patients With First Relapsed Anaplastic Astrocytoma (Study P03745)
Sponsor:
Merck Sharp & Dohme LLC